Breathe Well Live Well
 Healio |
Asthma development tied to genetic makeup, wheezing illness
Healio All of the 200 children in the COAST cohort had at least one parent with asthma, respiratory allergies or both. The 297 Danish children in the COPSAC cohort were born to mothers with asthma. Both groups of children were evaluated for asthma from aged 6 … |
View full post on asthma – Google News
|
BPA exposure allegedly tied to development of asthma
Lexology (registration) A recent study has reportedly identified “an association between postnatal urinary bisphenol A (BPA) concentrations and asthma in children.” Kathleen Donohue, et al., “Prenatal and postnatal bisphenol A exposure and asthma development among inner-city … |
View full post on asthma – Google News
|
Differences in viral illness patterns play a role in asthma development in …
News-Medical.net Children living in low-income urban areas appear especially prone to developing asthma, possibly related to infections they acquire early in life. In a new study in The Journal of Infectious Diseases, available online, researchers from the University … |
View full post on asthma – Google News
|
Development of a core outcome set for clinical trials in childhood asthma: a …
7thSpace Interactive (press release) Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people – up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment … |
View full post on asthma – Google News
|
Actelion ends development of asthma and SAR drug
Pharma Times Actelion has suffered a pipeline setback with the failure of its asthma and seasonal allergic rhinitis drug setipiprant in a mid-stage and a late-stage trial. The Swiss biotech says that it will "re-direct its development efforts in the … |
View full post on asthma – Google News
|
Actelion to end setipiprant clinical development in asthma, allergic rhinitis
RTT News PK: News ) on Monday said two recently concluded studies with the first orally-active CRTH2 antagonist, setipiprant, in asthma and seasonal allergic rhinitis did not confirm efficacy findings made in earlier studies. Accordingly, the company is … Actelion provides update on CRTH2 program |
View full post on asthma – Google News
|
Neonatal Size Associated With Asthma Development
Doctors Lounge Larger neonates born at term to mothers with a history of asthma are more likely to develop asthma by age 7, but are not more likely to have allergic sensitization or atopic dermatitis, according to research published online March 2 in Allergy. |
View full post on asthma – Google News
|
Belly fat can trigger the development of Asthma
Hindustan Times Belly fat can trigger the development of Asthma Belly fat, which was previously linked with diabetes and heart disease, could also trigger asthma, shows research from the University of Science and Technology in Norway. A study of 23245 adults without … |
View full post on asthma – Google News
|
Revalesio Presenting RNS60 Data at ACAAI
Drug Discovery & Development ACAAI (American College of Allergy, Asthma and Immunology) is a professional association with more than 5000 members devoted to the specialty of allergy and immunology. In this first in man asthma study, RNS60 demonstrated therapeutic benefit and … |
View full post on asthma – Google News
|
Kissei funds for MediciNova asthma drug development
Pharmaceutical Business Review Kissei Pharmaceutical is funding $2.5m to support further clinical development of MediciNova's MN-221 to treat acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD). As per the license agreenent signed between the two companies … MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd … Kissei To Pay MediciNova $2.5 Mln To Support Clinical Development Of MN-221 MediciNova Inc expects USD2.5m from Kissei Pharmaceutical Co Ltd for MN-221 … |
View full post on asthma – Google News